Metraipolis › archive › dc_b6a321c13802

Case Report: pembrolizumab monotherapy achieves durable disease control in a patient with BRAF V600E-mutant advanced lung adenocarcinoma and high PD-L1… — Europe PMC PMID:41777654

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41777654
DOI
10.3389/fonc.2026.1720971
License (as archived)
solo-consultazione
Archived
2026-11-05T18:14:47.782Z
SHA-256 of the archived text
0f0cb1afc4eef54b079507dfb28400ed70996085a865e84aac9b88bf863269cb
Stable URL of this page
https://metraipolis.com/documento/dc_b6a321c13802

How to cite

Case Report: pembrolizumab monotherapy achieves durable disease control in a patient with BRAF V600E-mutant advanced lung adenocarcinoma and high PD-L1… — Europe PMC PMID:41777654 — Europe PMC (en), https://europepmc.org/article/MED/41777654 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b6a321c13802 (Metraipolis archive dc_b6a321c13802, sha256 0f0cb1afc4eef54b079507dfb28400ed70996085a865e84aac9b88bf863269cb)
BibTeX
@misc{dcb6a321c13802,
  title = {Case Report: pembrolizumab monotherapy achieves durable disease control in a patient with BRAF V600E-mutant advanced lung adenocarcinoma and high PD-L1… — Europe PMC PMID:41777654},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41777654},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b6a321c13802; sha256 0f0cb1afc4eef54b079507dfb28400ed70996085a865e84aac9b88bf863269cb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41777654. Agents can read the archived copy with the MCP tool read_document.